Abstract
Polymorphonuclear leukocyte (PMN) migration is measured in whole blood in a migration chamber consisting of a membrane filter (3-μm pores, 140μm thick) with an integrated chemoattractant depot (FMLP in solid form) attached to a plastic container. Control chambers lack FMLP (blanks). One test unit requires 300μl blood. Numbers and distribution of the PMN immigrants into the filters are determined microscopically. Altogether 26 measurements of PMN migration in five juvenile rheumatoid arthritis (JRA) patients with varying disease activity were compared with the reactions of a healthy control group (N=32). Correlations were calculated with conventional laboratory parameters (WBC, PLT, BSR, CRP, Hgb, serum Fe) and disease activity. In comparison with healthy controls, PMNs of JRA patients generally show a markedly increased penetration depth into the filters irrespective the presence of the chemoattractant or the disease activity. Increased migratory reactions to FMLP in comparison to blanks were found during high disease activity only. The PMN penetration depth correlates positively with the CRP, and reciprocally with the Hgb blood levels. The migration assay combines fast and simple processing with good preservation of the genuine PMN activation state.
Similar content being viewed by others
References
Baum, J. 1975. Chemotaxis in human disease.In The Phagocytic Cell in Host Resistance. J. A. Bellanti and D. H. Dayton, editors. Raven Press, New York. 283–293.
Goddard, D. H., A. P. Kirk, J. R. Kirwan, G. D. Johnson, andE. J. Holborow. 1984. Impaired polymorphnuclear leukocyte chemotaxis in rheumatoid arthritis.Ann. Rheum. Dis. 43:151–156.
King, S. L., J. Parker, R. Cooper, R. Sturrock, andG. C. Gemmel. 1986. Polymorphnuclear leukocyte function in rheumatoid arthritis.Br. J. Rheumatol. 25:26–33.
Turner, R. A., J. A. Johnson, andS. R. Turner. 1987. Neutrophil responsiveness to chemoattractant tripeptide in rheumatoid arthritis.Proc. Soc. Exp. Biol. Med. 186:125–133.
Brown, K. A. 1988. The polymorphnuclear cell in rheumatoid arthritis.Br. J. Rheumatol. 27:150–155.
Espersen, G. T., E. Ernst, M. Vestergaard, J. O. Pedersen, andN. Grunnet. 1989. Change in PMN leukocyte migration activity and complement C3d levels in RA patients with high disease activity during steroid treatment.Scand. J. Rheumatol. 18:51–56.
Harris, E. D.. Rheumatoid arthritis. Pathophysiology and implication for therapy. 1990.N. Engl. J. Med. 322:1277–1289.
Wallace, C. A., andJ. E. Levinson. 1991. Juvenile rheumatoid arthritis: Outcome and treatment for the 1990s.Rheum. Dis. North Am. 17:891–905.
Leirisalo-Repo, M., L. Paimela, S. Koskimies, andH. Repo. 1993. Functions of polymorphnuclear leukocytes in early rheumatoid arthritis.Inflammation 17:427–442.
Wakefield, J. S. J., J. S. Gale, M. V. Berridge, T. W. Jordan, andH. C. Ford. 1982. Is Percoll innocuous to cells?Biochem. J. 202:795.
Colas-Linhard, N. 1984. Techniques of cell handling and viability testing.In Blood Cells in Nuclear Medicine, Part II. Migratory Blood Cells. G. F. Fueger, editor. Martinus Nijhoff Publishers. The Hague. 117–132.
Bignold, L. P. 1987. Effects of preparative technique on the rate of adoption of crawling-like movements by polymorphnuclear leukocytes.Cell Biol. Int. Rep. 11:19–25.
Korsatko, W., andG. Egger. 1988. Der Einsatz von Liberationsstablisatoren bei Augendiagnoseplättchen zur unblutigen Messung der Leukocytenmigration am Menschen. 1988.Pharmazie 43:776–779.
Ansell, B. H. 1990. Classification and nomenclature.In Pediatric Rheumatology Update. P. Woo, P. H. White, and B. M. Ansell, editors. Oxford University Press, New York. 3–5.
Wilkinson, P. C. 1974. Chemotaxis and Inflammation. Churchill Livingstone, Edinburgh and London. 50–52.
Koj, A. 1985. Definition and classification of acute-phase proteins.In The Acute-Phase Response to Injury and Infection. A. H. Gordon and A. Koj, editors. Elsevier, Amsterdam. 139–144.
Whicher, J. T., J. Gauldie, H. Baumann, andC. Westacott. 1989. Acute phase proteins.In Interleukin-1, Inflammation and Disease. R. Bomford and B. Henderson, editors. Elsevier, Amsterdam. 192–216.
Van Rijswijk, M. H., andM. A. Van Leeuwen. 1989. C-reactive protein: Clinical aspects.In Acute Phase Proteins in the Acute Phase Response. M. B. Pepys, editor. Springer-Verlag, London. 161–168.
Koj, A. 1985. Regulation of synthesis of acute-phase proteins.In The Acute Phase Response to Injury and Infection. A. H. Gordon and A. Koj, editors. Elsevier, Amsterdam. 205–220.
Ciliberto, G. 1989. Transscriptional regulation of acute phase response genes with emphasis on the human C-reactive protein gene.In Acute Phase Proteins in the Acute Phase Response. M. B. Pepys, editor. Springer-Verlag, London. 29–46.
Roodman, G. D. 1987. Mechanisms of erythroid suppression in the anemia of chronic disease.Blood Cells 13:171–184.
Woldawer, L. I., M. A. Marano, H. Wei, Y. Fong, M. L. Silen, G. Kuo, K. R. Manogue, H. Vlassar, H. Cohen, andA. Cerami. 1989. Cachektin/tumor necrosis factor-α alters red blood cell kinetics and induces anemia in vivo.FASEB J. 3:1637–1643.
Danis, V. A., G. M. Franic, D. A. Rathen, R. M. Laurent, andP. M. Brooks. 1992. Circulating cytokine levels in patients with rheumatoid arthritis: results of a double blind trial with sulphasalazine.Ann. Rheum. Dis. 13:946–950.
Wolf, R. E., W. G. Brelsford, V. C. Hall, andS. B. Adams, 1992. Cytokines and soluble interleukin-2 receptors in rheumatoid arthritis.J. Rheumatol. 19:524–528.
Altomonte, L., A. Zoli, L. Mirone, P. Scolieri, andM. Magaro. 1992. Serum levels of interleukin-1b, tumor nekrosis factor-α and interleukin-2 in rheumatoid arthritis. Correlation with disease activity.Clin. Rheumatol. 11:202–205.
Barrera, P., A. M. Boerbooms, E. M. Janssen, R. W. Sauerwein, H. Galatti, J. Mulder, T. De Boo, P. N. Demacker, L. B. Van der Putte, andJ. W. Van der Meer. 1993. Circulating soluble tumor necrosis factor receptors, interleukin-2 receptors, tumor necrosis factor alpha, and interleukin-6 levels in rheumatoid arthritis. Longitudinal evaluation during methotrexate and azathioprine therapy.Arthritis Rheum. 36:1070–1079.
Feldmann, M., F. M. Brennan, R. O. Williams, A. P. Cope, D. L. Gibbons, P. D. Katsikis, andR. N. Maini. 1992. Evaluation of the role of cytokines in autoimmune disease: the importance of TNF alpha in rheumatoid arthritis.Progr. Growth Factor Res. 4:247–255.
Egger, G. 1991. Priming of polymorphnuclear leukocytes (PMN) by cytokines demonstrated with a new whole-blood membrane filter migration assay. International Congress on Inflammation, Rome (Italy), October 1991. Abstract book 165.
Haines, K. A., J. Reibmann, andG. Weissmann. 1988. Triggering and activation of human neutrophils. Two aspects of the response to transmembrane signals.In Cellular and Molecular Aspects of Inflammation. G. Poste and S. T. Crooke, editors. Plenum Press, New York. 31–40.
Henson, P. M., J. E. Henson, C. Fittschen, G. Kimani, D. L. Bratton, andD. W. H. Riches. 1988. Phagocytic cells: Degranulation and secretion.In Inflammation. Basic Principles and Clinical Correlates. J. I. Gallin, I. M. Goldstein, and R. Snyderman, editors. Raven Press, New York. 363–390.
Bajaj, M. S., R. R. Kew, R. O. Webster, andT. M. Hyers. 1992. Priming of human neutrophil functions by tumor necrosis factor: Enhancement of Superoxide anion generation, degranulation, and chemotaxis to chemoattractants C5a and F-Met-Leu-Phe.Inflammation 16:241–250.
Follin, P., andC. Dahlgren. 1992. Phagocytosis by lipopolysaccharide-primed human neutrophils is associated with increased extracellular release of reactive oxygen metabolites.Inflammation 16:83–91.
Baggiolini, M. 1992. Interleukin-8 (NAP) and Related Chemotactic Cytokines. Karger, Basel. 8.
Zigmond, S. H. 1978. A model for understanding millipore filter assay systems.In Leukocyte Chemotaxis: Methods, Physiology, and Clinical Implications. J. I. Gallin and P. G. Quie, editors. Raven Press, New York. 87–96.
Ford-Hutchinson, A. W. 1983. The role of leukotriene B4 as a mediator of leukocyte function.In Leukocyte Locomotion and Chemotaxis. H. Keller, G. O. Till, and A. Arbor, editors. Birkhäuser-Verlag, Stuttgart. 154–166.
Lewis, R. A., andK. F. Austen. 1988. Leukotrienes.In Inflammation. Basic Principles and Clinical Correlates. J. I. Gallin, I. M. Goldstein, and R. Snyderman, editors. Raven Press, New York. 121–128.
Nourshargh, S., andT. J. Williams. 1991. Mechanisms of granulocyte-dependent oedema.In Vascular Endothelium: Interactions with Circulating Cells. J. L. Gordon, editor. Elsevier, Amsterdam. 161–174
Egger, G., S. Porta, andD. Gollmann. 1982. Neutrophil aggregation during migration in vivo.Inflammation 6:147–159.
Boyden, S. V. 1962. The chemotactic effect of mixtures of antibody and antigen on polymorphnuclear leukocytes.J. Exp. Med. 15:453–466.
Rice, J. E., andL. P. Bignold. 1992. Chemotaxis of polymorphnuclear leukocytes in whole blood in the “sparse pore” polycarbonate (Nucleopore) membrane/Boyden chamber assay.J. Immunol. Methods 149:121–125.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Egger, G., Klemt, C., Spendel, S. et al. Migratory activity of blood polymorphnuclear leukocytes during juvenile rheumatoid arthritis, demonstrated with a new wholeblood membrane filter assay. Inflammation 18, 427–441 (1994). https://doi.org/10.1007/BF01534440
Issue Date:
DOI: https://doi.org/10.1007/BF01534440